Qualitative criteria: Management | Weighting: 7.5% |
---|---|
Qualitative criteria: Management 2022 Results>
|
Qualitative criteria: Image, Company reputation, Dialogue with stakeholders | Weighting: 7.5% |
---|---|
Qualitative criteria: Image, Company reputation, Dialogue with stakeholders
|
Pursuant in particular to Articles L. 225-197-1 and L. 22-10-8 of the French Commercial Code and the authorisation of the Ordinary and Extraordinary General Meeting of 21 April 2022,the Board of Directors meeting on 13 October 2022, taking in to account the performance of Mr Nicolas Hieronimusand the share price valuation, decided to grant him 20,000performance shares (ACAs – “Attributions Conditionnelles d’Actions”, existing conditional grants of shares), in accordance with the remuneration policy.
The estimated fair value, according to the IFRS standards applied in preparing the Consolidated Financial Statements, of one performance share (ACAs) for the 13 October 2022 plan, of which Mr Nicolas Hieronimus is part, is €303.33.
The estimated fair value, according to the IFRS standards, of the 20,000 performance shares (ACAs) granted in 2022 to Mr Nicolas Hieronimus is therefore €6,066,600.
These shares will only vest, in whole or in part, once conditions described below are met.
Final vesting of these shares is subject to achievement of performance conditions which will be recorded at the end of a four-year vesting period as from the grant date.
The number of fully vested shares will depend on growth incomparable cosmetics sales compared to the growth of a panel of competitors, which consists in 2022 of Unilever, Procter & Gamble, Estée Lauder, Shiseido, Beiersdorf, Johnson & Johnson, Henkel, LVMH, Kao, and Coty (40%); on the growth in the Group’s consolidated operating profit (40%); on the achievement of environmental and social responsibility commitments made by the Group as part of the L’Oréal for the Future programme (15%) and on a gender balance target in strategic positions including the Executive Committee (5%).
The calculation will be based on the arithmetical average fort he 3 full financial years of the vesting period. The first full year taken into account for assessment of the performance conditions relating to this grant is 2023.
As regards all the free shares granted pursuant to the criterion relating to sales, in order for these to finally vest at the end of the vesting period, L’Oréal must outperform the average growth in sales of the panel of competitors. Below this level, the grant decreases. If the L’Oréal’s comparable growth in net sales is lower than the average growth in net sales of the panel of competitors, no shares will be finally vested under this criterion.